Dr. Cecilia Canales selected for NAM Scholars in Diagnostic Excellence Program
CTSI congratulates Dr. Cecilia Canales, a previous RCMAR/CHIME awardee, supported in part by the CTSI
Cecilia Canales, M.D., M.P.H., assistant professor of anesthesiology & perioperative medicine at the David Geffen School of Medicine has been selected for the 2023-2024 National Academy of Medicine (NAM) Scholars in Diagnostic Excellence program in collaboration with the Council of Medical Specialty Societies. Dr. Canales was chosen through a national competition based on her professional qualifications and accomplishments, demonstrated leadership in the field, and potential to advance diagnostic excellence and equity. She was also chosen based on the quality and feasibility of her program proposal submission: “Advancing Language Equity in Diagnosing Perioperative Neurocognitive Disorders.”
Funded by the Gordon and Betty Moore Foundation, with additional support from The John A. Hartford Foundation (JAHF), the program is designed to develop a cadre of leaders who can drive implementation of effective strategies to raise awareness of diagnosis in medicine, support diagnostic excellence, and reduce diagnostic errors at the national level. Up to 11 scholars participate in the one-year, part-time remote experience to enhance their knowledge and skills in diagnostic quality, safety, and equity and accelerate their career development in becoming national leaders in the field. The program includes monthly educational sessions, mentorship, a $35,000 grant, and an additional $5,000 domestic travel funds.
Click here to continue reading.
Image source: UCLA Health